Compared with low-risk patients (defined by the POISE criteria, ALP < 1.67 × ULN and bilirubin < 1 × ULN), the expression level of TXNIP, ENTPD1, and CD44 was upregulated in high-risk PBC patients with statistical significance. This evidence concerns the gene CD44 and primary biliary cholangitis.